IRIS
ORA, JOSUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.842
AS - Asia 2.541
EU - Europa 1.650
SA - Sud America 362
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 31
OC - Oceania 11
Totale 17.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.741
SG - Singapore 1.222
IT - Italia 442
CN - Cina 424
HK - Hong Kong 295
BR - Brasile 291
RU - Federazione Russa 248
VN - Vietnam 199
IE - Irlanda 160
FR - Francia 148
DE - Germania 142
PL - Polonia 121
UA - Ucraina 114
BD - Bangladesh 90
KR - Corea 90
GB - Regno Unito 85
JP - Giappone 63
CA - Canada 49
FI - Finlandia 49
NL - Olanda 37
IN - India 36
SE - Svezia 31
MX - Messico 27
ID - Indonesia 24
AR - Argentina 20
ES - Italia 16
AT - Austria 15
TR - Turchia 14
EC - Ecuador 13
VE - Venezuela 12
AU - Australia 11
BE - Belgio 11
IQ - Iraq 11
ZA - Sudafrica 11
PH - Filippine 9
CL - Cile 7
JM - Giamaica 7
MY - Malesia 7
PK - Pakistan 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
CR - Costa Rica 6
EG - Egitto 6
PT - Portogallo 6
PY - Paraguay 6
UZ - Uzbekistan 6
IR - Iran 5
LT - Lituania 5
PE - Perù 5
TW - Taiwan 5
JO - Giordania 4
KE - Kenya 4
KW - Kuwait 4
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
MA - Marocco 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
IL - Israele 2
LB - Libano 2
PR - Porto Rico 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.442
Salva come PNG Salva come JPEG
Città #
Wilmington 2.855
Woodbridge 2.777
Houston 2.697
Singapore 569
Fairfield 465
Ashburn 393
San Jose 366
Hong Kong 287
Chandler 218
Ann Arbor 216
Seattle 207
Council Bluffs 202
Cambridge 146
Dublin 140
Beijing 135
New York 118
Santa Clara 112
Medford 110
Kraków 104
Rome 101
Monte Vista 95
Los Angeles 86
Dallas 80
The Dalles 74
Dearborn 71
Ho Chi Minh City 68
Jacksonville 63
Tokyo 58
Lauterbourg 52
Lawrence 50
Hanoi 48
Moscow 44
Milan 42
Buffalo 39
Chicago 34
San Diego 34
São Paulo 31
Zhengzhou 28
San Francisco 24
Naples 23
Chaozhou 20
Phoenix 19
Brooklyn 17
Colorado Springs 17
Guangzhou 17
North Bergen 17
Redondo Beach 17
Jakarta 16
Montreal 15
Nuremberg 15
Orem 15
Warsaw 15
Chennai 14
Denver 14
Salt Lake City 14
Toronto 14
Frankfurt am Main 13
Helsinki 13
London 13
Lappeenranta 12
Rio de Janeiro 12
Verona 11
Atlanta 10
Belo Horizonte 10
Miami 10
Munich 10
Norwalk 10
Palo Alto 10
Menlo Park 9
Brussels 8
Hefei 8
Johannesburg 8
Mexico City 8
Shenzhen 8
Bari 7
Boston 7
Charlotte 7
Columbus 7
Da Nang 7
Hải Dương 7
Norwich 7
Poplar 7
Redwood City 7
Seoul 7
Amsterdam 6
Detroit 6
Elk Grove Village 6
Haiphong 6
Kingston 6
Kunming 6
Porto Alegre 6
Quito 6
San José 6
Stockholm 6
Tampa 6
Vienna 6
Boardman 5
Caracas 5
City of London 5
Guayaquil 5
Totale 13.863
Salva come PNG Salva come JPEG
Nome #
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 517
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 504
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 491
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 487
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 485
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 484
Optimizing drug delivery in COPD: The role of inhaler devices 483
Airflow obstruction: Is it asthma or is it COPD? 482
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 479
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 461
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease 448
Role of muscarinic antagonists in asthma therapy 441
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD 439
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 435
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 433
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 432
Dog allergen immunotherapy and allergy to furry animals 428
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 423
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 421
Adherence to COPD treatment: Myth and reality 417
Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease 392
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 390
Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD 370
Cardiopulmonary exercise test in athletes and coronary diseases|Test cardiopolmonare da sforzo negli atleti e nelle patologie coronariche 366
Dual bronchodilation and exacerbations of COPD 360
Canakinumab for the treatment of chronic obstructive pulmonary disease 344
The safety of dual bronchodilation on cardiovascular serious adverse events in COPD 296
The future of inhalation therapy in chronic obstructive pulmonary disease 282
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: A quantitative synthesis 281
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 240
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease 235
β-Blockers and Asthma: Surprising findings from the FAERS database 231
Efficacy and safety profile of doxofylline compared to theophylline in asthma: A meta-analysis 216
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 216
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 209
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 190
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 173
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 170
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers 163
Does bronchoscopy help the diagnosis in COVID-19 infection? 148
Advances with glucocorticoids in the treatment of asthma: state of the art 128
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 127
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis 123
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 115
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 113
The BNT162b2 mRNA COVID-19 vaccine increases the contractile sensitivity to histamine and parasympathetic activation in a human ex vivo model of severe eosinophilic asthma 105
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement 104
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 99
An overview of the safety and efficacy of monoclonal antibodies for the chronic obstructive pulmonary disease 99
Use of Thiols in the Treatment of COVID-19: Current Evidence 97
Exercise-Induced Asthma: Managing Respiratory Issues in Athletes 94
A clinician’s guide to single vs multiple inhaler therapy for COPD 93
New avenues for phosphodiesterase inhibitors in asthma 93
Treatable Mechanisms in Asthma 92
Hyperglycaemia and Chronic Obstructive Pulmonary Disease 91
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients 90
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways 90
Guidance on nebulization during the current COVID-19 pandemic 90
Strength of association between comorbidities and asthma: a meta-analysis 85
Sex differences in COPD management 85
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis 84
Studio real-life sui pazienti con asma grave in terapia biologica: focus sulla funzionalità respiratoria 82
Investigational anti IL-13 asthma treatments: a 2023 update 82
Step-up and step-down approaches in the treatment of asthma 80
Management of COPD patients during COVID: difficulties and experiences 80
Indacaterol/Glycopyrronium Combination for COPD 78
Pulmonary Rehabilitation in Noncystic Fibrosis Bronchiectasis 76
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences 74
Happy hypoxemia, or blunted ventilation? 73
Current long-acting muscarinic antagonists for the treatment of asthma 73
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: a translational bench-to-bedside study 68
Synergy across the drugs approved for the treatment of asthma 62
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance 60
Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional Study 59
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 59
Biologic therapies for chronic obstructive pulmonary disease 58
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutions 58
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 55
Totale 17.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022500 0 37 11 12 7 37 119 18 23 58 48 130
2022/2023594 102 44 24 60 54 138 48 34 49 7 18 16
2023/2024276 48 7 31 9 18 55 5 45 5 9 4 40
2024/20251.966 49 397 184 78 60 70 152 133 161 249 231 202
2025/20263.545 240 258 288 270 348 99 414 360 438 234 398 198
2026/2027446 277 169 0 0 0 0 0 0 0 0 0 0
Totale 17.736